Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00876993
Title Study of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors All Children’s Hospital Johns Hopkins Medicine
Indications

medulloblastoma

childhood ependymoma

high grade glioma

Therapies

Bevacizumab + Irinotecan + Temozolomide

Age Groups: child
Covered Countries USA


No variant requirements are available.